Researchers have discovered that the chemical gadolinium in MRI and MRA scans could cause ocular plaque calcification. Doctors have been denying that gadolinium causes any adverse reactions, yet researchers disagree. This study proves the medical community wrong.

About Gadolinium

Gadolinium is a chemical element carrying the atomic number 64 and the atomic symbol Gd. Belonging to a group of elements in the periodic table called Lanthanides, the chemical is a rare earth element typically used in microwave applications, color TV tubes, synthetic gemstones, compact discs, and computer memory. The medical community uses this chemical element as an injectable contrast agent when patients undergo magnetic resonance Imaging (MRI) and magnetic resonance angiography (MRA) scans.

Gadolinium Ocular Plaque Calcification

JAMA has published a study studying ocular effects of gadolinium. For the past 10 years, researchers have studied the after-effects in patients reporting multiple symptoms of gadolinium retention. They noticed that those with a high level of gadolinium still in the body produced calcium salt deposits in the eyes. This could lead to chronic renal failure, hyperparathyroidism, sarcoidosis, and calciphylaxis. Gadolinium deposits in tissues could cause calcification in the organs. Now, it is found in the eyes as well.

Effects of Gadolinium Retention

The FDA conducted a review of the AERS database along with additional literature and found many reports of GDD. Many of which happened within hours to days after receiving a GBCA. The immediate symptoms listed are:

• Pain and burning sensation at origin site
• Cognitive difficulties
• Central nervous system problems
• Skin and musculoskeletal complaints

Many end up bedridden or in wheelchairs due to their loss of mobility and pain. It doesn’t matter a patient’s health beforehand. Top level athletes or young parents have been unable to work again after GDD. Treatments are costly, and there is not a cure.

Free Case Evaluation

A gadolinium lawsuit may be an option for patients suffering from gadolinium retention and related complications. Gadolinium, used in dyes to increase the clarity of MRI and MRA scans, can create chemical element retention in the body, Therefore, this increases the risk of gadolinium deposition disease and nephrogenic systemic fibrosis. These conditions are accompanied by symptoms that include severe physical pain and cognitive difficulties. Affected patients and their loved ones may be able to file a lawsuit and recover damages.
For more information, contact The Michael Brady Lynch Firm. We offer free, confidential, no obligation consultations. We have over 20 years of experience helping consumers injured by unsafe products manufactured by large companies.